Holen Sie sich die Stockscreener-App
46.70
6.11%
2.69
Handel nachbörslich:
46.70
Schlusskurs vom Vortag:
$44.01
Offen:
$43.83
24-Stunden-Volumen:
1.23M
Relative Volume:
1.28
Marktkapitalisierung:
$3.69B
Einnahmen:
$399.58M
Nettoeinkommen (Verlust:
$-54.04M
KGV:
-62.27
EPS:
-0.75
Netto-Cashflow:
$40.13M
1W Leistung:
+18.89%
1M Leistung:
+27.14%
6M Leistung:
+71.94%
1J Leistung:
+17.96%
1-Tages-Spanne:
$43.24
$46.93
1-Wochen-Bereich:
$37.98
$46.93
52-Wochen-Spanne:
$22.61
$47.32
Veracyte Inc Stock (VCYT) Company Profile
Firmenname
Veracyte Inc
Sektor
Branche
Telefon
(650) 243-6300
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie VCYT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
46.70 | 3.48B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Hold |
| 2025-03-20 | Eingeleitet | Craig Hallum | Buy |
| 2024-12-05 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-16 | Eingeleitet | UBS | Buy |
| 2024-10-10 | Eingeleitet | Guggenheim | Buy |
| 2024-02-23 | Bestätigt | Needham | Buy |
| 2023-01-18 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-11-18 | Fortgesetzt | Goldman | Buy |
| 2021-06-15 | Eingeleitet | Raymond James | Outperform |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Underweight |
| 2019-07-31 | Eingeleitet | Lake Street | Buy |
| 2019-07-02 | Eingeleitet | Needham | Buy |
| 2018-11-29 | Herabstufung | Janney | Buy → Neutral |
| 2018-10-31 | Hochstufung | Janney | Neutral → Buy |
| 2017-11-07 | Herabstufung | Janney | Buy → Neutral |
| 2017-11-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Fortgesetzt | BTIG Research | Buy |
| 2016-11-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-18 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-11 | Bestätigt | Leerink Partners | Outperform |
| 2013-11-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
Veracyte Stock Soars Amid Strong Earnings and New Price Targets - timothysykes.com
Veracyte Stock Surges Amid Investor Conferences and Robust Earnings - StocksToTrade
Is Veracyte Inc a good long term investmentMoving Average Crossovers & AI-Based Insights for Consistent Profits - earlytimes.in
Veracyte Stock Soars Amid Revenue and EPS Surprises - timothysykes.com
Veracyte, Inc. (NASDAQ:VCYT) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Insider Sell: Jens Holstein Sells 10,000 Shares of Veracyte Inc (VCYT) - GuruFocus
Veracyte Director Jens Holstein Sells 10,000 Shares - TradingView
Dir Holstein Sells 10,000 ($423.6K) Of Veracyte Inc [VCYT] - TradingView
[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan
Will Veracyte Inc. (12V) stock sustain bullish trend into 2025Earnings Overview Summary & Safe Entry Point Identification - newser.com
Can Veracyte Inc. (12V) stock surprise markets with earningsTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
Veracyte at Stephens Conference: Strategic Growth and Expansion By Investing.com - Investing.com India
Veracyte at Stephens Conference: Strategic Growth and Expansion - Investing.com
Veracyte at Jefferies London: Strategic Expansion and Growth By Investing.com - Investing.com Nigeria
Veracyte at Jefferies London: Strategic Expansion and Growth - Investing.com
Will Veracyte Inc. stock gain from government policiesShort Setup & Weekly High Conviction Trade Ideas - newser.com
Will Veracyte Inc. (12V) stock profit from fiscal stimulus2025 Key Lessons & Capital Efficiency Focused Strategies - newser.com
Can Veracyte Inc. (12V) stock sustain breakout momentumRisk Management & Daily Entry Point Alerts - newser.com
How Veracyte Inc. stock performs in interest rate cyclesPortfolio Return Summary & Daily Profit Focused Screening - newser.com
How to read the order book for Veracyte Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Tools to assess Veracyte Inc.’s risk profileEarnings Beat & AI Enhanced Trading Alerts - newser.com
Is Veracyte Inc. (12V) stock cheap vs fundamentalsGap Down & Verified Momentum Stock Watchlist - newser.com
Heatmap analysis for Veracyte Inc. and competitorsMarket Trend Review & Step-by-Step Trade Execution Guides - newser.com
Finanzdaten der Veracyte Inc-Aktie (VCYT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.35%
1.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):